Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Priti S. Hegde

机构：Foundation Medicine (United States)

发表论文 264 篇 · 总被引 34140 次 · h-index 51

代表论文

  • Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers (2023 · Cancer Cell · 被引 36)
  • Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response (2023 · JCO Precision Oncology · 被引 26)
  • Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling–informed personalized monitoring assay (2023 · Frontiers in Oncology · 被引 12)
  • Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors (2024 · PLoS ONE · 被引 8)
  • Supplementary Data Table S3 from Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response (2023)
  • Supplementary Data Figure S5 from Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response (2023)